Laparoscopic Management of Colorectal Liver Metastases

  • Thomas Satyadas
  • Zahra Shafaee
  • Brice GayetEmail author


Colorectal cancer is the third most common cancer worldwide, with a lifetime risk of approximately 5 %. The most common site for haematogenous metastasis is the liver. Approximately 10–20 % of patients with colorectal adenocarcinoma will have synchronous hepatic metastasis at the time of diagnosis, and 20–25 % of the patients will develop metachronous metastasis later in life. Without treatment, the prognosis of colorectal cancer with liver metastasis is poor, and the 5-year survival rate is less than 5 %. At present, liver resection offers the best chance of survival for patients with colorectal cancer liver metastasis. Currently the 5-year survival rate following curative resection of colorectal liver metastasis approaches 45–60 %. Many reasons have contributed to the better results of colorectal liver metastasis. Improved patient selection in a multidisciplinary team setting, increased understanding of liver surgery and anaesthesia, technological improvements, advances made in diagnostic and interventional radiology and advances made in the field of chemotherapy are to name a few contributory factors.


Liver Resection Hepatic Resection Colorectal Liver Metastasis Laparoscopic Liver Resection Repeat Hepatectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Science+Business Media Dordrecht and People's Medical Publishing House 2017

Authors and Affiliations

  1. 1.Department of Digestive DiseaseInstitut Mutualiste Montsouris, Université Paris-DescartesParisFrance

Personalised recommendations